ABBOTT LABORATORIES — Operating Income by Fiscal Year

19 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/1098caa2-1007-4c12-9e80-d55ce45f20f4/serie/operating-income

Fiscal yearOperating IncomePeriodEvidence
FY 2025$8.1B2025-01-01 – 2025-12-31evidence 0001628280-26-010185
FY 2024$6.8B2024-01-01 – 2024-12-31evidence 0001628280-25-007110
FY 2023$6.5B2023-01-01 – 2023-12-31evidence 0001628280-24-005348
FY 2022$8.4B2022-01-01 – 2022-12-31evidence 0001628280-23-004026
FY 2021$8.4B2021-01-01 – 2021-12-31evidence 0001104659-22-025141
FY 2020$5.4B2020-01-01 – 2020-12-31evidence 0001104659-21-025751
FY 2019$4.5B2019-01-01 – 2019-12-31evidence 0001104659-20-023904
FY 2018$3.6B2018-01-01 – 2018-12-31evidence 0001047469-19-000624
FY 2017$1.6B2017-01-01 – 2017-12-31evidence 0001047469-19-000624
FY 2016$3.0B2016-01-01 – 2016-12-31evidence 0001047469-19-000624
FY 2015$2.9B2015-01-01 – 2015-12-31evidence 0001047469-16-010246
FY 2014$2.6B2014-01-01 – 2014-12-31evidence 0001047469-15-001377
FY 2013$2.1B2013-01-01 – 2013-12-31evidence 0001047469-15-001377
FY 2012$1.4B2012-01-01 – 2012-12-31evidence 0001047469-15-001377
FY 2011$1.6B2011-01-01 – 2011-12-31evidence 0001047469-14-001176
FY 2010$6.1B2010-01-01 – 2010-12-31evidence 0001047469-11-001056
FY 2009$6.2B2009-01-01 – 2009-12-31evidence 0001047469-10-001018
FY 2008$5.7B2008-01-01 – 2008-12-31evidence 0001047469-10-001018
FY 2007$4.6B2007-01-01 – 2007-12-31evidence 0001047469-10-001018
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

ABBOTT LABORATORIES — all facts · Revenue · Net Income